Published in J Thorac Cardiovasc Surg on December 13, 2012
Left ventricular assist devices: a kidney's perspective. Heart Fail Rev (2015) 1.99
Regional differences in recipient waitlist time and pre- and post-transplant mortality after the 2006 United Network for Organ Sharing policy changes in the donor heart allocation algorithm. JACC Heart Fail (2014) 1.57
Organ donation in the UK: how general practice can help. Br J Gen Pract (2013) 1.05
Dilemmas in end-stage heart failure. J Geriatr Cardiol (2015) 0.86
Gastrointestinal Bleeding During the Index Hospitalization for Mechanical Circulatory Support Devices Implantation, a Nationwide Perspective. Dig Dis Sci (2016) 0.83
Effect of Different Rotational Directions of BJUT-II VAD on Aortic Swirling Flow Characteristics: A Primary Computational Fluid Dynamics Study. Med Sci Monit (2016) 0.79
Institutional volume of heart transplantation with left ventricular assist device explantation influences graft survival. J Heart Lung Transplant (2014) 0.75
Early feasibility testing and engineering development of a sutureless beating heart connector for left ventricular assist devices. ASAIO J (2014) 0.75
The study on hemodynamic effect of series type LVAD on aortic blood flow pattern: a primary numerical study. Biomed Eng Online (2016) 0.75
LVAD Outflow Graft Angle and Thrombosis Risk. ASAIO J (2016) 0.75
General and acute care surgical procedures in patients with left ventricular assist devices. World J Surg (2014) 0.75
Left Ventricular Assist Devices Impact Hospital Resource Utilization Without Affecting Patient Mortality in Gastrointestinal Bleeding. Dig Dis Sci (2016) 0.75
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med (2001) 18.91
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00
Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med (2009) 12.77
The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report--2011. J Heart Lung Transplant (2011) 3.01
Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries. JAMA (2008) 2.96
The Fourth INTERMACS Annual Report: 4,000 implants and counting. J Heart Lung Transplant (2012) 2.69
Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy. Circ Heart Fail (2011) 1.99
Left ventricular assist devices as permanent heart failure therapy: the price of progress. Ann Surg (2003) 1.30
Temporal changes in hospital costs for left ventricular assist device implantation. J Card Surg (2011) 1.04
Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era. J Heart Lung Transplant (2006) 1.03
The economics of heart transplantation. Circulation (1987) 0.87
REMATCH and beyond: the cost of treating heart failure using an implantable left ventricular assist device. Semin Cardiothorac Vasc Anesth (2006) 0.82
Medicare program; solicitation of hospitals and medical centers to participate in a study of heart transplants: Health Care Financing Administration. Notice. Fed Regist (1981) 0.82
Heart transplants: to pay or not to pay. Science (1980) 0.81
Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med (2014) 7.23
Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med (2013) 6.21
Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med (2015) 4.77
Blood transfusion and infection after cardiac surgery. Ann Thorac Surg (2013) 3.35
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. N Engl J Med (2015) 3.11
Central cannulation is safe in acute aortic dissection repair. J Thorac Cardiovasc Surg (2006) 2.98
The role of methylene blue in serotonin syndrome following cardiac transplantation: a case report and review of the literature. J Thorac Cardiovasc Surg (2012) 2.86
Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation. Circulation (2005) 2.67
Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation. J Am Coll Cardiol (2004) 2.62
Predicted risk of mortality models: surgeons need to understand limitations of the University HealthSystem Consortium models. J Am Coll Surg (2009) 2.10
Does the Society of Thoracic Surgeons risk score accurately predict operative mortality for patients with pulmonary hypertension? J Thorac Cardiovasc Surg (2012) 2.09
Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg (2002) 1.91
Initial experience of sequential surgical epicardial-catheter endocardial ablation for persistent and long-standing persistent atrial fibrillation with long-term follow-up. Ann Thorac Surg (2011) 1.87
Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol (2006) 1.80
Ex vivo rehabilitation of non-heart-beating donor lungs in preclinical porcine model: delayed perfusion results in superior lung function. J Thorac Cardiovasc Surg (2012) 1.73
Primary payer status affects mortality for major surgical operations. Ann Surg (2010) 1.69
Do you need to clamp a patent left internal thoracic artery-left anterior descending graft in reoperative cardiac surgery? Ann Thorac Surg (2009) 1.63
In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice. J Pharmacol Exp Ther (2005) 1.54
Cost-analysis of percutaneous pulmonary valve implantation compared to surgical pulmonary valve replacement. Catheter Cardiovasc Interv (2013) 1.53
Smooth muscle phenotypic modulation is an early event in aortic aneurysms. J Thorac Cardiovasc Surg (2009) 1.53
High spatial resolution magnetic resonance imaging of cystic adventitial disease of the popliteal artery. J Vasc Surg (2010) 1.52
Is mitral valve repair superior to replacement in elderly patients? Ann Thorac Surg (2008) 1.52
Percutaneous intentional extraluminal recanalization in patients with chronic critical limb ischemia. Radiology (2004) 1.51
Sleep deprivation does not affect operative results in cardiac surgery. Ann Thorac Surg (2004) 1.51
Pressure frequency characteristics of the pericardial space and thorax during subxiphoid access for epicardial ventricular tachycardia ablation. Heart Rhythm (2010) 1.50
Coronary artery bypass with ventricular restoration is superior to coronary artery bypass alone in patients with ischemic cardiomyopathy. J Thorac Cardiovasc Surg (2004) 1.50
Proinflammatory response of alveolar epithelial cells is enhanced by alveolar macrophage-produced TNF-alpha during pulmonary ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol (2007) 1.48
Is off-pump coronary artery bypass grafting superior to conventional bypass in octogenarians? J Thorac Cardiovasc Surg (2010) 1.47
Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgery. J Thorac Cardiovasc Surg (2013) 1.45
Comparison of systemic and retrograde delivery of adenosine A2A agonist for attenuation of spinal cord injury after thoracic aortic cross-clamping. Ann Thorac Surg (2006) 1.44
Additive protection against lung ischemia-reperfusion injury by adenosine A2A receptor activation before procurement and during reperfusion. J Thorac Cardiovasc Surg (2007) 1.42
Replacement of the proximal aorta adds no further risk to aortic valve procedures. Ann Thorac Surg (2007) 1.40
Mitral stenosis caused by an amplatzer occluder device used to treat a paravalvular leak. Ann Thorac Surg (2012) 1.39
Attending, house officer, and medical student perceptions about teaching in the third-year medical school general surgery clerkship. J Am Coll Surg (2004) 1.39
Caring for the residents: the view of two program directors. Ann Thorac Surg (2004) 1.38
Surgical ventricular restoration: the RESTORE Group experience. Heart Fail Rev (2004) 1.37
Natural killer T cell-derived IL-17 mediates lung ischemia-reperfusion injury. Am J Respir Crit Care Med (2011) 1.35
CD4+ T lymphocytes mediate acute pulmonary ischemia-reperfusion injury. J Thorac Cardiovasc Surg (2009) 1.28
Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol (2013) 1.23
Adenosine A2A receptor activation reduces inflammation and preserves pulmonary function in an in vivo model of lung transplantation. J Thorac Cardiovasc Surg (2005) 1.22
Endoscopic versus open saphenous vein harvest for femoral to below the knee arterial bypass using saphenous vein graft. J Vasc Surg (2006) 1.18
Tumor recurrence after complete resection for non-small cell lung cancer. Ann Thorac Surg (2012) 1.18
Optimal surgical management of severe ischemic mitral regurgitation: to repair or to replace? J Thorac Cardiovasc Surg (2011) 1.17
Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg (2009) 1.17
Unusual complications of percutaneous epicardial access and epicardial mapping and ablation of cardiac arrhythmias. Circ Arrhythm Electrophysiol (2011) 1.16
Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcine lung transplantation model. J Thorac Cardiovasc Surg (2011) 1.16
Outcomes of surgical aortic valve replacement in high-risk patients: a multiinstitutional study. Ann Thorac Surg (2011) 1.14
The role of adenosine A2A receptor signaling in bronchiolitis obliterans. Ann Thorac Surg (2009) 1.13
NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. Am J Respir Cell Mol Biol (2008) 1.13
Adenosine signaling via the adenosine 2B receptor is involved in bronchiolitis obliterans development. J Heart Lung Transplant (2010) 1.12
Magnetic resonance imaging identifies the fibrous cap in atherosclerotic abdominal aortic aneurysm. Circulation (2004) 1.11
Mitral repair is superior to replacement when associated with coronary artery disease. Ann Surg (2004) 1.11
Model-based design of mechanical therapies for myocardial infarction. J Cardiovasc Transl Res (2010) 1.11
Bone marrow-derived MCP1 required for experimental aortic aneurysm formation and smooth muscle phenotypic modulation. J Thorac Cardiovasc Surg (2011) 1.11
Tumor necrosis factor-alpha from resident lung cells is a key initiating factor in pulmonary ischemia-reperfusion injury. J Thorac Cardiovasc Surg (2004) 1.11
Hospital procedure volume should not be used as a measure of surgical quality. Ann Surg (2012) 1.09
Does reperfusion injury still cause significant mortality after lung transplantation? J Thorac Cardiovasc Surg (2009) 1.09
The effect of surgeon volume on mortality for off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg (2012) 1.08
Circulating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarker. Ann Thorac Surg (2011) 1.07
A simplified approach to degenerative disease: triangular resections of the mitral valve. Ann Thorac Surg (2007) 1.07
Adenosine A₂A agonist improves lung function during ex vivo lung perfusion. Ann Thorac Surg (2011) 1.07
Cardiac injury during resternotomy does not affect perioperative mortality. J Am Coll Surg (2008) 1.07
The impact of coronary artery endarterectomy on outcomes during coronary artery bypass grafting. J Card Surg (2011) 1.07